According to the National Sleep Foundation  (2013), about 30–40% of the general population reports some level of  insomnia during their lives, and 10–15% experience significant, chronic  insomnia. For these individuals, medications to help induce and sustain  sleep may be helpful. On the other hand, sleep aids pose potential  concerns, namely abuse. Some people exceed recommended doses, and some  continue taking medications even after symptoms are no longer present.  Others obtain medications under false pretenses, which is one form of  malingering. Malingering occurs when clients make up or exaggerate  symptoms for some personal gain. Although mental health professionals  may not be directly implicated in the client’s deceit, their unique  position to receive more accurate and honest information than other  medical professionals presents ethical concerns. What is the mental  health professional’s role in these instances? In which instances would  it be appropriate to break confidentiality due to a concern of  malingering? How could the malingering potentiality be planned for and  avoided? For this Assignment, conduct an  Internet search or a Walden Library search for at least one  peer-reviewed journal article that addresses a counseling issue related  to malingering and addiction in treating sleep disorders. By Day 7 In a 3-page, APA-formatted paper, include the following: A description and explanation of the major types of drugs prescribed for sleep disorders An explanation of the potential for addiction associated with these medicines An explanation of the issues related to malingering in the treatment of sleep disorders An explanation of the mental health professional’s role in mitigating the potentialities of malingering Lichtblau, L. (2011). Psychopharmacology demystified . Clifton Park, NY: Delmar, Cengage Learning. Chapter 6, “Anxiolytic-Sedative-Hypnotic Drug Pharmacotherapy” (previously read in Week 5) Preston, J. D., O’Neal, J. H., & Talaga, M. C. (2017). Handbook of clinical psychopharmacology for therapists (8th ed.). Oakland, CA: New Harbinger. Chapter 15, “Other Miscellaneous Disorders” (pp. 161-174) National Institute of Neurological Disorders and Stroke. (2014). Brain basics: Understanding sleep . Retrieved from http://www.ninds.nih.gov/disorders/brain_basics/understanding_sleep.htm#sleep_disorders As you review this website, consider the types of sleep disorders associated with mental health treatment .

1. According to the National Sleep Foundation (2013), about 30–
40% of the general population reports some level of insomnia
during their lives, and 10–15% experience significant, chronic
insomnia. For these individuals, medications to help induce and
sustain sleep may be helpful. On the other hand, sleep aids
pose potential concerns, namely abuse. Some people exceed
recommended doses, and some continue taking medications
even after symptoms are no longer present. Others obtain
medications under false pretenses, which is one form of
malingering. Malingering occurs when clients make up or
exaggerate symptoms for some personal gain. Although mental
health professionals may not be directly implicated in the
client’s deceit, their unique position to receive more accurate
and honest information than other medical professionals
presents ethical concerns. What is the mental health
professional’s role in these instances? In which instances would
it be appropriate to break confidentiality due to a concern of
malingering? How could the malingering potentiality be
planned for and avoided?
For this Assignment, conduct an Internet search or a Walden
Library search for at least one peer-reviewed journal article
that addresses a counseling issue related to malingering and
addiction in treating sleep disorders.
By Day 7
In a 3-page, APA-formatted paper, include the following:
A description and explanation of the major types of drugs
prescribed for sleep disorders
An explanation of the potential for addiction associated with
these medicines

2. An explanation of the issues related to malingering in the
treatment of sleep disorders
An explanation of the mental health professional’s role in
mitigating the potentialities of malingering
Lichtblau, L. (2011).
Psychopharmacology demystified
. Clifton Park, NY: Delmar, Cengage Learning.
Chapter 6, “Anxiolytic-Sedative-Hypnotic Drug
Pharmacotherapy” (previously read in Week 5)
Preston, J. D., O’Neal, J. H., & Talaga, M. C. (2017).
Handbook of clinical psychopharmacology for therapists
(8th ed.). Oakland, CA: New Harbinger.
Chapter 15, “Other Miscellaneous Disorders” (pp. 161-174)
National Institute of Neurological Disorders and Stroke. (2014).
Brain basics: Understanding sleep
. Retrieved from
http://www.ninds.nih.gov/disorders/brain_basics/understanding_
sleep.htm#sleep_disorders

3. As you review this website, consider the types of sleep
disorders associated with mental health treatment